Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex
European Organisation for Research and Treatment of Cancer
InstitutionResearch output, impact & collaborations
European Organisation for Research and Treatment of Cancer is a research organisation in Brussels, BE. OpenAlex records 3,581 works and 766,352 citations for it. 519 researchers list it as their most recent affiliation.
3,581
Works
766,352
Citations
519
Researchers
50.8
Avg h-index
How has European Organisation for Research and Treatment of Cancer's publication output changed over time?
ScholarIQpublication output · 1987–2021
Output grew0% over the shown period — from 1 works in 1987 to 1 in 2021.
1
1
1
1
1
1
1
1987200520092018201920202021
What are the most-cited papers on European Organisation for Research and Treatment of Cancer?
ScholarIQmost cited works
Adjuvant Pembrolizumab versus Placebo in Resected Stage III Melanoma
Alexander M.M. Eggermont, Christian U. Blank, Mario Mandalà, Georgina V. Long, Victoria Atkinson, Stéphane Dalle, Andrew Haydon, Mikhail Lichinitser, Adnan Khattak, Matteo S. Carlino, Shahneen Sandhu, James Larkin, Susana Puig, Paolo A. Ascierto, Piotr Rutkowski, Dirk Schadendorf, Rutger H.T. Koornstra, Leonel F. Hernandez‐Aya, Michele Maio, Alfonsus Johannes Maria van den Eertwegh, Jean-Jacques Grob, Ralf Gutzmer, Rahima Jamal, Paul Lorigan, Nageatte Ibrahim, Sandrine Marréaud, Alexander C. J. van Akkooi, Stefan Suciu, Caroline Robert
New England Journal of Medicine. 20181,870 CitationsOPEN ACCESS
The development of the EORTC QLQ-C15-PAL: A shortened questionnaire for cancer patients in palliative care
Mogens Grøenvold, Morten Aagaard Petersen, Neil K. Aaronson, Juan Ignacio Arrarás, Jane Blazeby, Andrew Bottomley, Peter Fayers, Alexander de Graeff, Eva Hammerlid, Stein Kaasa, Mirjam A. G. Sprangers, Jakob Bue Bjørner
European Journal of Cancer. 2005696 Citations
Preoperative radiotherapy plus surgery versus surgery alone for patients with primary retroperitoneal sarcoma (EORTC-62092: STRASS): a multicentre, open-label, randomised, phase 3 trial
Sylvie Bonvalot, Alessandro Gronchi, C. Le Péchoux, Carol J. Swallow, D. Strauß, Pierre Méeus, Frits van Coevorden, Stephan Stoldt, Eberhard Stoeckle, Piotr Rutkowski, Marco Rastrelli, Chandrajit P. Raut, Daphne Hompes, Antonino De Paoli, Claudia Sangalli, Charles Honoré, Peter Chung, Aisha Miah, Jean‐Yves Blay, Marco Fiore, Jean‐Jacques Stelmes, Angelo Paolo Dei Tos, Elizabeth H. Baldini, Saskia Litière, Sandrine Marréaud, Hans Gelderblom, Rick L. Haas
The Lancet Oncology. 2020492 CitationsOPEN ACCESS
The value of preoperative radiotherapy in esophageal cancer: Results of a study of the E.O.R.T.C.
M Gignoux, A Roussel, B Paillot, M Gillet, P. Schlag, Jean‐Pierre Favre, Otilia Dalesio, Marc Buyse, N. Duez
World Journal of Surgery. 1987295 Citations
Phase 3 Randomized Trial on Larynx Preservation Comparing Sequential vs Alternating Chemotherapy and Radiotherapy
Jean Louis Lefèbvre, Frédéric Rolland, Margot Tesselaar, É. Bardet, C. René Leemans, Lionnel Geoffrois, P. Hupperets, Luigi Barzan, D. De Raucourt, Dominique Chevalier, Lisa Licitra, F Lunghi, Roger Stupp, Denis Lacombe, Jan Bogaerts, Jean-Claude Horiot, J. Bernier, Jan B. Vermorken, for the EORTC Head and Neck Cancer Cooperative Group and the EORTC Radiation Oncology Group
JNCI Journal of the National Cancer Institute. 2009282 CitationsOPEN ACCESS
How much of the research on European Organisation for Research and Treatment of Cancer is open access?
ScholarIQopen access share
71%OPEN ACCESS
Gold
0%
Green
0%
Hybrid
29%
Bronze
43%
Closed
29%